Loading...
•
Dec 31, 2021
PROCEPT BioRobotics Q4 2021 Earnings Report
Reported financial results for the fourth quarter and full year ended December 31, 2021.
Key Takeaways
PROCEPT BioRobotics reported Q4 2021 revenue of $10.1 million, a significant increase from $3.2 million in the same period of 2020. The growth was primarily driven by system sales to new hospital customers and increased utilization among existing customers. The company's gross margin also improved substantially, reaching 44.5% compared to 14.6% in the prior year period.
Revenue of $10.1 million for the fourth quarter of 2021, compared to $3.2 million from the same period of 2020
U.S. system and rental revenue of $5.0 million for the fourth quarter of 2021, compared to $1.2 million in the prior year period
U.S. handpiece and consumables revenue of $3.4 million for the fourth quarter of 2021, compared to $0.8 million in the prior year period
Gross margin for the fourth quarter 2021 was 44.5% compared to 14.6% in the prior year period
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company projects revenue for the first quarter of 2022 to be in the range of $12.0 million to $12.5 million and full year 2022 revenue to be in the range of $54.0 million to $58.0 million and gross margin to be in the range of 47.0% to 49.0%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...